646 related articles for article (PubMed ID: 35457124)
1. Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review.
Kamperman RG; van der Kooi AJ; de Visser M; Aronica E; Raaphorst J
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457124
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic inflammatory myopathies.
Lundberg IE; Fujimoto M; Vencovsky J; Aggarwal R; Holmqvist M; Christopher-Stine L; Mammen AL; Miller FW
Nat Rev Dis Primers; 2021 Dec; 7(1):86. PubMed ID: 34857798
[TBL] [Abstract][Full Text] [Related]
3. The role of interferons type I, II and III in myositis: A review.
Bolko L; Jiang W; Tawara N; Landon-Cardinal O; Anquetil C; Benveniste O; Allenbach Y
Brain Pathol; 2021 May; 31(3):e12955. PubMed ID: 34043262
[TBL] [Abstract][Full Text] [Related]
4. [Idiopathic inflammatory myopathies. A review].
Acosta I; Matamala JM; Jara P; Pino F; Gallardo A; Verdugo R
Rev Med Chil; 2019 Mar; 147(3):342-355. PubMed ID: 31344172
[TBL] [Abstract][Full Text] [Related]
5. Classification of idiopathic inflammatory myopathies: pathology perspectives.
Tanboon J; Nishino I
Curr Opin Neurol; 2019 Oct; 32(5):704-714. PubMed ID: 31369423
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory muscle disease - An update.
Baig S; Paik JJ
Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101484. PubMed ID: 32046904
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic myopathies.
Mammen AL
Handb Clin Neurol; 2024; 200():327-332. PubMed ID: 38494286
[TBL] [Abstract][Full Text] [Related]
8. Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies.
Casal-Dominguez M; Pinal-Fernandez I; Corse AM; Paik J; Albayda J; Casciola-Rosen L; Johnson C; Danoff SK; Christopher-Stine L; Tiniakou E; Mammen AL
Neurology; 2019 Mar; 92(13):e1416-e1426. PubMed ID: 30824556
[TBL] [Abstract][Full Text] [Related]
9. Current Classification and Management of Inflammatory Myopathies.
Schmidt J
J Neuromuscul Dis; 2018; 5(2):109-129. PubMed ID: 29865091
[TBL] [Abstract][Full Text] [Related]
10. Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity.
Mahoudeau A; Anquetil C; Tawara N; Khademian H; Amelin D; Bolko L; Silvestro M; Cin JD; Tendrel B; Tardif V; Mariampillai K; Butler-Browne G; Benveniste O; Allenbach Y
Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12849. PubMed ID: 36168256
[TBL] [Abstract][Full Text] [Related]
11. Possible future avenues for myositis therapeutics: DM, IMNM and IBM.
Connolly CM; Plomp L; Paik JJ; Allenbach Y
Best Pract Res Clin Rheumatol; 2022 Jun; 36(2):101762. PubMed ID: 35778272
[TBL] [Abstract][Full Text] [Related]
12. Nailfold videocapillaroscopy alterations in dermatomyositis, antisynthetase syndrome, overlap myositis, and immune-mediated necrotizing myopathy.
Soubrier C; Seguier J; Di Costanzo MP; Ebbo M; Bernit E; Jean E; Veit V; Swiader L; Salort-Campana E; Attarian S; De Paula AM; Kaplanski G; Durand JM; Harlé JR; Schleinitz N
Clin Rheumatol; 2019 Dec; 38(12):3451-3458. PubMed ID: 31440919
[TBL] [Abstract][Full Text] [Related]
13. What is New in Idiopathic Inflammatory Myopathies: Mechanisms and Therapies.
Khadilkar SV; Dhamne MC
Ann Indian Acad Neurol; 2020; 23(4):458-467. PubMed ID: 33223661
[TBL] [Abstract][Full Text] [Related]
14. Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical Use.
Gandiga PC; Ghetie D; Anderson E; Aggrawal R
Curr Rheumatol Rep; 2023 Aug; 25(8):152-168. PubMed ID: 37261663
[TBL] [Abstract][Full Text] [Related]
15. Radiographic patterns of muscle involvement in the idiopathic inflammatory myopathies.
Day JA; Bajic N; Gentili S; Patel S; Limaye V
Muscle Nerve; 2019 Nov; 60(5):549-557. PubMed ID: 31397909
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic inflammatory myopathies.
Dimachkie MM; Barohn RJ; Amato AA
Neurol Clin; 2014 Aug; 32(3):595-628, vii. PubMed ID: 25037081
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.
Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S
Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.
Yang H; Tian X; Zhang L; Li W; Liu Q; Jiang W; Peng Q; Wang G; Lu X
BMC Musculoskelet Disord; 2022 May; 23(1):425. PubMed ID: 35524238
[TBL] [Abstract][Full Text] [Related]
19. Quantitative whole-body muscle MRI in idiopathic inflammatory myopathies including polymyositis with mitochondrial pathology: indications for a disease spectrum.
Zierer LK; Naegel S; Schneider I; Kendzierski T; Kleeberg K; Koelsch AK; Scholle L; Schaefer C; Naegel A; Zierz S; Otto M; Stoltenburg-Didinger G; Kraya T; Stoevesandt D; Mensch A
J Neurol; 2024 Jun; 271(6):3186-3202. PubMed ID: 38438820
[TBL] [Abstract][Full Text] [Related]
20. The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review.
Gasparotto M; Franco C; Zanatta E; Ghirardello A; Zen M; Iaccarino L; Fabris B; Doria A; Gatto M
Autoimmun Rev; 2023 Jun; 22(6):103334. PubMed ID: 37068699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]